文献速递临床试验与 GCP

交互式双眼治疗(I-BiT)用于3.5-12岁儿童屈光参差性、斜视性及混合性弱视管理的临床研究计划:一项随机对照试验

Clinical investigation plan for the use of interactive binocular treatment (I-BiT) for the management of anisometropic, strabismic and mixed amblyopia in children aged 3.5-12 years: a randomised controlled trial.
PubMed 文献 · Trials · 2019-07-16

本研究为随机对照试验,纳入3.5至12岁屈光参差性、斜视性及混合性弱视儿童,每组40例,共三组,按1:1随机分为I-BiT组与对照组,在家治疗6周。主要终点为基线至治疗结束时视力变化,次要终点包括其他视力指标、可接受性、依从性及不良事件发生率。

要点

  • I-BiT为基于立体技术及快门眼镜的双眼分视刺激系统,本试验采用重新设计并具备眼动追踪功能的家庭用版本。
  • 三组分别为屈光参差性弱视、斜视手术前混合或斜视性弱视、刚接受斜视手术后的混合或斜视性弱视,每组40例。
  • 主要终点为基线至治疗结束(第6周)的视力变化,活性治疗组在第10周加测。

核心结论

  • 本随机对照试验旨在确定重新设计的I-BiT™系统是否为屈光参差性、斜视性及混合性弱视管理的可行治疗策略。

研究设计与样本

  • 随机对照试验,纳入三组各40例、年龄3.5至12岁、诊断为屈光参差性弱视、斜视手术前混合或斜视性弱视、刚接受斜视手术后混合或斜视性弱视的儿童。
  • 受试者按1:1比例随机分配至I-BiT组与对照组,在家接受为期6周的治疗。
  • 视力在基线、治疗中期(第3周)、治疗结束(第6周)独立评估,活性I-BiT治疗组在治疗结束后4周(第10周)加测。

主要发现

  • 主要终点为基线至治疗结束的视力变化。
  • 次要终点包括其他视力指标、患者可接受性、依从性及不良事件发生率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Amblyopia (lazy eye) affects the vision of approximately 2% of all children. Traditional treatment consists of wearing a patch over their 'good' eye for a number of hours daily, over several months. This treatment is unpopular and compliance is often low. Therefore, results can be poor. I-BiT is a system, based on stereo technology using shutter glasses, designed to treat amblyopia using dichoptic stimulation. This trial uses a redesigned system for home use and includes eye-tracking capability. METHODS/DESIGN: This is a randomised controlled trial involving three groups of 40 patients each, aged between 3.5 and 12 years, with a diagnosis of (1) anisometropic amblyopia, (2) mixed or strabismic amblyopia prior to strabismic surgery and (3) mixed or strabismic amblyopia who have just undergone strabismus surgery. They will be randomised in a 1:1 ratio between I-BiT and control and will receive treatment, at home over a 6-week period. Their visual acuity will be assessed independently at baseline, mid-treatment (week 3), at the end of treatment (week 6) and, for those receiving the active I-BiT treatment, 4 weeks after completing treatment (week 10). The primary endpoint will be the change in visual acuity from baseline to the end of treatment. Secondary endpoints will be additional visual acuity measures, patient acceptability, compliance and the incidence of adverse events. DISCUSSION: This is a randomised controlled trial using the redesigned I-BiT™ system to determine if this is a feasible treatment strategy for the management of anisometropic, strabismic and mixed amblyopia. TRIAL REGISTRATION: ISRCTN Number/Clinical trials.gov, ID: NCT02810847 . Registered on 23 June 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Brown R, Blanchfield P, Fakis A, et al. Clinical investigation plan for the use of interactive binocular treatment (I-BiT) for the management of anisometropic, strabismic and mixed amblyopia in children aged 3.5-12 years: a randomised controlled trial. Trials. 2019. PMID: 31311577. doi:10.1186/s13063-019-3523-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。